Showing 2,045 news articles about PrEP

Filters Content type: Editors' picks Topic: PrEP

Pre-exposure prophylaxis involves people who do not have HIV taking antiretroviral drugs when they are at risk of exposure to HIV in order to prevent infection. The drugs are usually taken as pills (oral PrEP).

Pharmaceutical industry

HIV Affects Millions of Women. So Why Isn’t a New PrEP Drug Approved for Their Use?

Editor's pick
Rewire News
3 December 2019
PrEP policies & guidelines

Boris Johnson wants you to ‘fight’ HIV despite not including a single commitment to PrEP in Tory manifesto

Editor's pick
Pink News
2 December 2019
PrEP policies & guidelines

If the NHS was ‘for sale,’ what would it mean for PrEP?

Editor's pick
PinkNews
2 December 2019
PrEP policies & guidelines

General election 2019: Labour and Lib Dems pledge wider access to HIV drug

Editor's pick
BBC News
2 December 2019
PrEP programmes & uptake

South Africa: HIV PrEP is available, but why aren’t people taking it?

Editor's pick
Daily Maverick
2 December 2019
HIV treatment

Top 10 HIV Clinical Developments of 2019

Editor's pick
TheBodyPro
27 November 2019
People & personal stories

8 Months Ago, I Was Diagnosed with HIV While on PrEP

Editor's pick
TheBody
26 November 2019
PrEP programmes & uptake

People Seeking PrEP Face Numerous Nonfinancial Roadblocks

Editor's pick
POZ
25 November 2019
Government, leadership & policy

The World Cannot End HIV Without Continued Innovation

Editor's pick
POZ
25 November 2019
PrEP policies & guidelines

Barring cisgender women from the Descovy trials was a bad call

Editor's pick
STAT
25 November 2019
New & experimental HIV treatments

ViiV Healthcare announces exclusive licensing agreement with the National Institutes of Health for investigational "bNAb" with potential for long-acting HIV treatment and prevention

Editor's pick
ViiV Healthcare press release
21 November 2019
People & personal stories

The Berlin Patient, the First Person Ever Cured of HIV, on Taking PrEP: "I Want a Full Sexual Life"

Editor's pick
TheBodyPro
12 November 2019
HIV prevention policy

Did The CDC's Jonathan Mermin Prevent PrEP Access to the Public?

Editor's pick
HIV Plus
12 November 2019
Pharmaceutical industry

Untangling the Trump administration's lawsuit over an HIV prevention drug

Editor's pick
Science
11 November 2019
PrEP science

Descovy for PrEP Continues to Be Noninferior to Truvada, According to 96 Week Data

Editor's pick
Monthly Prescribing Reference
8 November 2019
Pharmaceutical industry

U.S. sues drugmaker Gilead over patents on HIV prevention treatment

Editor's pick
San Francisco Chronicle
8 November 2019
Bad science & bogus treatments

Misleading Ads About PrEP Are Threatening Progress to End the HIV Epidemic. They Must Be Removed.

Editor's pick
TheBodyPro
7 November 2019
PrEP policies & guidelines

United States Files Patent Infringement Lawsuit Against Gilead Related to Truvada® and Descovy® for Pre-exposure Prophylaxis of HIV

Editor's pick
U.S. Department of Health & Human Services
7 November 2019
PrEP policies & guidelines

Lloyd Russell-Moyle MP: England must have full access to the drug that stops people getting HIV

Editor's pick
PoliticsHome
4 November 2019
PrEP science

Future PrEP Drugs, Delivery Methods, Technologies Target Adherence Issue

Editor's pick
American Journal of Managed Care
1 November 2019
PrEP science

Where Were the Women? Gender Parity in Clinical Trials

Editor's pick
New England Journal of Medicine (free registration required)
31 October 2019
PrEP policies & guidelines

What Needs to Happen Before California Pharmacies Can Sell PrEP and PEP Without an Initial Prescription

Editor's pick
TheBodyPro
29 October 2019
PrEP policies & guidelines

PrEP in Ireland: what you need to know about the new programme

Editor's pick
GCN
28 October 2019
PrEP policies & guidelines

Men eligible for HIV drug trial in Manchester contracted virus while on waiting list

Editor's pick
Manchester Evening News
23 October 2019